EU Pharmaceutical Strategy Roadmap: high time to improve patient access to medicines and to apply the lessons from Covid19

European Parliament report calls for increased use of… 24 November 2021 Open
Smart reform of EU pharma and IP legislation key to boosting… 28 June 2022 Generic and biosimilar medicines lower healthcare treatment costs dramatically and…
"Off patent medicines essential for a fairer, healthier, and… 30 April 2021 Christoph Stoller will speak at 3A CONFERENCE - Availability, Accessibility,…
European patients need improved access to biosimilar… 22 April 2021 Fifteen years after the first global approval, biosimilar medicines systemically…